Different initial steps of apoptosis induced by two types of antineoplastic drugs

Biochemical Pharmacology

Volumn 76, Issue 3, 2008, Pages 303-311

  Takagi, Yasumitsu ^a   Hidaka, Masumi ^a   Sanada, Masayuki ^a   Yoshida, Hiroki ^b   Sekiguchi, Mutsuo ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

ACNU; Apoptosis; DNA repair; MGMT; Temozolomide

Indexed keywords

6 O CHLOROETHYLGUANINE; 6 O METHYLGUANINE; ANTINEOPLASTIC AGENT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; GUANINE DERIVATIVE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; PHOSPHATIDYLSERINE; TEMOZOLOMIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL LINE; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; MGMT GENE; MISMATCH REPAIR; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; DACARBAZINE; DNA DAMAGE; DNA REPAIR; FIBROBLASTS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; NIMUSTINE; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOSPHATIDYLSERINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 46649091107     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.05.008     Document Type: Article

References (34)

1. Drablos F., Feyzi E., Aas P.A., Vaagbo C.B., Kavli B., Bratlie M.S., et al. Alkylation damage in DNA and RNA-repair mechanisms and medical significance. DNA Repair (Amst) 3 (2004) 1389-1407
2. Friedman H.S., Kerby T., and Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res 6 (2000) 2585-2597
3. Sanada M., Hidaka M., Takagi Y., Takano T.Y., Nakatsu Y., Tsuzuki T., et al. Modes of actions of two types of antineoplastic drugs, dacarbazine and ACNU, to induce apoptosis. Carcinogenesis 28 (2007) 2657-2663
4. Tentori L., and Graziani G. Pharmacological strategies to increase the antitumor activity of methylating agents. Curr Med Chem 9 (2002) 1285-1301
5. Marchesi F., Turriziani M., Tortorelli G., Avvisati G., Torino F., and De Vecchis L. Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res 56 (2007) 275-287
6. Sanada M., Takagi Y., Ito R., and Sekiguchi M. Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. DNA Repair (Amst) 3 (2004) 413-420
7. Carter S.K., Schabel Jr. F.M., Broder L.E., and Johnston T.P. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. Adv Cancer Res 16 (1972) 273-332
8. Schabel Jr. F.M. Nitrosoureas: a review of experimental antitumor activity. Cancer Treat Rep 60 (1976) 665-698
9. Roos W.P., Batista L.F., Naumann S.C., Wick W., Weller M., Menck C.F., et al. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26 (2007) 186-197
10. Wedge S.R., Porteus J.K., May B.L., and Newlands E.S. Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro. Br J Cancer 73 (1996) 482-490
11. Yoshioka K., Yoshioka Y., and Hsieh P. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol Cell 22 (2006) 501-510
12. Hidaka M., Takagi Y., Takano T.Y., and Sekiguchi M. PCNA-MutSalpha-mediated binding of MutLalpha to replicative DNA with mismatched bases to induce apoptosis in human cells. Nucleic Acids Res 33 (2005) 5703-5712
13. Kaina B., Christmann M., Naumann S., and Roos W.P. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 6 (2007) 1079-1099
14. Margison G.P., and Santibanez-Koref M.F. O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays 24 (2002) 255-266
15. 6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy. Curr Opin Pharmacol 6 (2006) 355-363
16. Takagi Y., Takahashi M., Sanada M., Ito R., Yamaizumi M., and Sekiguchi M. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis. DNA Repair (Amst) 2 (2003) 1135-1146
17. Yoshida H., Kong Y.Y., Yoshida R., Elia A.J., Hakem A., Hakem R., et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94 (1998) 739-750
18. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., et al. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc Nat Acad Sci U S A 95 (1998) 5116-5120
19. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., and van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 (1994) 1415-1420
20. Adrain C., and Martin S.J. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26 (2001) 390-397
21. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 15 (2001) 2922-2933
22. Tsujimoto Y., Nakagawa T., and Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 1757 (2006) 1297-1300
23. Cossarizza A., Kalashnikova G., Grassilli E., Chiappelli F., Salvioli S., Capri M., et al. Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level. Exp Cell Res 214 (1994) 323-330
24. Baranovskaya S., Soto J.L., Perucho M., and Malkhosyan S.R. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci U S A 98 (2001) 15107-15112
25. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
26. Flohr T., Dai J.C., Buttner J., Popanda O., Hagmuller E., and Thielmann H.W. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines. Int J Cancer 80 (1999) 919-929
27. Vincent F., Nagashima M., Takenoshita S., Khan M.A., Gemma A., Hagiwara K., et al. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene 15 (1997) 117-122
28. D'Atri S., Tentori L., Lacal P.M., Graziani G., Pagani E., Benincasa E., et al. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 54 (1998) 334-341
29. Liu L., Markowitz S., and Gerson S.L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res 56 (1996) 5375-5379
30. Kurz E.U., and Lees-Miller S.P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3 (2004) 889-900
31. Stojic L., Mojas N., Cejka P., Di Pietro M., Ferrari S., Marra G., et al. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev 18 (2004) 1331-1344
32. Hickman M.J., and Samson L.D. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol Cell 14 (2004) 105-116
33. 6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60 (2000) 5815-5824
34. Tomicic M.T., Christmann M., Fabian K., and Kaina B. Apaf-1 deficient mouse fibroblasts are resistant to MNNG and MMS-induced apoptotic death without attenuation of Bcl-2 decline. Toxicol Appl Pharmacol 207 (2005) 117-122